Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001048477-26-000008
Filing Date
2026-05-05
Accepted
2026-05-05 13:59:42
Documents
74
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bmrn-20260331.htm   iXBRL 10-Q 1355544
2 EX-31.1 bmrn-exx311xq12026.htm EX-31.1 9224
3 EX-31.2 bmrn-exx312xq12026.htm EX-31.2 9237
4 EX-32.1 bmrn-exx321xq12026.htm EX-32.1 5127
  Complete submission text file 0001048477-26-000008.txt   6952005

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmrn-20260331.xsd EX-101.SCH 41692
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bmrn-20260331_cal.xml EX-101.CAL 74221
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bmrn-20260331_def.xml EX-101.DEF 223975
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bmrn-20260331_lab.xml EX-101.LAB 575395
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmrn-20260331_pre.xml EX-101.PRE 413652
78 EXTRACTED XBRL INSTANCE DOCUMENT bmrn-20260331_htm.xml XML 968848
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

EIN.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26727 | Film No.: 26942126
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)